Clinical Trial

The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

Study acronym: DANWARD
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study aims to evaluate the appropriateness of initiating oral anticoagulation for stroke risk reduction in dialysis populations with atrial fibrillation. Specifically, the study will assess the overall safety, tolerability, and efficacy of initiating treatment with Warfarin in patients with end-stage renal disease on dialysis and atrial fibrillation.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2019-03-01; most recent amendment 2026-05-17.
Status change: Not Yet Recruiting → Recruiting 2019-10-16
Trial Details
NCT Number NCT03862859
Lead Sponsor Nicholas Carlson
Collaborators: Danish Heart Foundation
Conditions Atrial Fibrillation and Flutter, Stroke, Major Bleed, End-stage Renal Disease
Enrollment 718 participants
Start Date 2019-10-09
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-19